Status:
ACTIVE_NOT_RECRUITING
VT ART Consortium: Radioablation for Ventricular Tachycardia
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions:
Ventricular Tachycardia (VT)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The overall objective of the study is to evaluate the efficacy and safety of stereotactic radiation therapy in the non invasive ablation of ventricular tachycardia refractory to any other type treatme...
Detailed Description
By agreeing to participate in this study, the patient will undergo an initial evaluation to verify that his or her condition meets the inclusion criteria required for participation. At that visit, * ...
Eligibility Criteria
Inclusion
- Patients with refractory VT
- age \> 18 years
- Patients with ICDs for follow-up
- Ineligible for heart transplantation.
- Prognosis of not less than 1 year
- Ability to express autonomous consent to therapies or (in case of inability due to clinical condition) deferred consent (first indicated by the referring clinician, later expressed by the patient once recovered to autonomous condition
Exclusion
- Evaluation of ICD demonstrating polymorphic VT;
- Patients with INTERMACS class greater than 4;
- Patients with LVAD;
- Patients with active neoplastic disease undergoing oncological treatment.
Key Trial Info
Start Date :
November 26 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 31 2029
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT06922214
Start Date
November 26 2024
End Date
October 31 2029
Last Update
May 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Policlinico Universitario Agostino Gemelli IRCSS
Rome, RM, Italy, 00168